

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of vitamin D biosynthetic process (GO:0060556) | 5.69829676 |
| 2 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.40511062 |
| 3 | modulation by symbiont of host immune response (GO:0052553) | 5.40511062 |
| 4 | positive regulation by symbiont of host defense response (GO:0052509) | 5.40511062 |
| 5 | modulation by symbiont of host defense response (GO:0052031) | 5.40511062 |
| 6 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.40511062 |
| 7 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.40511062 |
| 8 | regulation of fever generation (GO:0031620) | 4.76502430 |
| 9 | regulation of T-helper 1 cell differentiation (GO:0045625) | 4.75454484 |
| 10 | regulation of chronic inflammatory response (GO:0002676) | 4.51209447 |
| 11 | regulation of vitamin metabolic process (GO:0030656) | 4.48861916 |
| 12 | response to muramyl dipeptide (GO:0032495) | 4.33967638 |
| 13 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.33277081 |
| 14 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.33277081 |
| 15 | macrophage activation involved in immune response (GO:0002281) | 4.31396640 |
| 16 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.12880590 |
| 17 | regulation of cytokine secretion involved in immune response (GO:0002739) | 4.11288281 |
| 18 | response to peptidoglycan (GO:0032494) | 4.04633203 |
| 19 | regulation of chemokine biosynthetic process (GO:0045073) | 3.97231903 |
| 20 | T-helper 1 type immune response (GO:0042088) | 3.83749446 |
| 21 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.69472748 |
| 22 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.68950563 |
| 23 | regulation of heat generation (GO:0031650) | 3.67688152 |
| 24 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.67391041 |
| 25 | microglial cell activation (GO:0001774) | 3.64149941 |
| 26 | NIK/NF-kappaB signaling (GO:0038061) | 3.59558403 |
| 27 | negative regulation of interleukin-12 production (GO:0032695) | 3.58359361 |
| 28 | defense response to protozoan (GO:0042832) | 3.56001206 |
| 29 | response to protozoan (GO:0001562) | 3.55072692 |
| 30 | immunoglobulin mediated immune response (GO:0016064) | 3.51751802 |
| 31 | positive regulation of interferon-alpha production (GO:0032727) | 3.50781198 |
| 32 | positive regulation of type 2 immune response (GO:0002830) | 3.46649295 |
| 33 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 3.41821756 |
| 34 | regulation of interferon-alpha production (GO:0032647) | 3.41601887 |
| 35 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.40992828 |
| 36 | positive regulation of acute inflammatory response (GO:0002675) | 3.40054177 |
| 37 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 3.38938069 |
| 38 | regulation of nitric oxide biosynthetic process (GO:0045428) | 3.38703239 |
| 39 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.38067270 |
| 40 | positive regulation of p38MAPK cascade (GO:1900745) | 3.35992946 |
| 41 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.35586334 |
| 42 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.34014528 |
| 43 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.33832496 |
| 44 | regulation of mononuclear cell migration (GO:0071675) | 3.32587436 |
| 45 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.26538440 |
| 46 | response to host immune response (GO:0052572) | 3.26538440 |
| 47 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.22757556 |
| 48 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.21905830 |
| 49 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 3.17849236 |
| 50 | regulation of integrin activation (GO:0033623) | 3.16640704 |
| 51 | positive regulation of interferon-beta production (GO:0032728) | 3.16402194 |
| 52 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.16220502 |
| 53 | macrophage activation (GO:0042116) | 3.12297460 |
| 54 | cellular response to lipopolysaccharide (GO:0071222) | 3.11657360 |
| 55 | activation of MAPKKK activity (GO:0000185) | 3.11616697 |
| 56 | regulation of T-helper cell differentiation (GO:0045622) | 3.10126622 |
| 57 | response to host (GO:0075136) | 3.09231417 |
| 58 | response to host defenses (GO:0052200) | 3.09231417 |
| 59 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.09231417 |
| 60 | regulation of gamma-delta T cell activation (GO:0046643) | 3.09028691 |
| 61 | regulation of type 2 immune response (GO:0002828) | 3.07348806 |
| 62 | regulation of immunoglobulin secretion (GO:0051023) | 3.05521304 |
| 63 | cellular response to molecule of bacterial origin (GO:0071219) | 3.03603644 |
| 64 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.03187965 |
| 65 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.02592099 |
| 66 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 3.01934289 |
| 67 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.00708964 |
| 68 | neutrophil activation involved in immune response (GO:0002283) | 3.00683593 |
| 69 | positive regulation of antigen processing and presentation (GO:0002579) | 3.00450716 |
| 70 | regulation of NF-kappaB import into nucleus (GO:0042345) | 2.99471332 |
| 71 | * response to type I interferon (GO:0034340) | 2.98814075 |
| 72 | * type I interferon signaling pathway (GO:0060337) | 2.96701283 |
| 73 | * cellular response to type I interferon (GO:0071357) | 2.96701283 |
| 74 | response to laminar fluid shear stress (GO:0034616) | 2.94355436 |
| 75 | apoptotic cell clearance (GO:0043277) | 2.92631776 |
| 76 | cell adhesion mediated by integrin (GO:0033627) | 2.91304231 |
| 77 | regulation of podosome assembly (GO:0071801) | 2.91229621 |
| 78 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.90679585 |
| 79 | positive regulation of interleukin-6 production (GO:0032755) | 2.88291288 |
| 80 | low-density lipoprotein particle clearance (GO:0034383) | 2.85911439 |
| 81 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.84244077 |
| 82 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.83174893 |
| 83 | tolerance induction (GO:0002507) | 2.83162115 |
| 84 | monocyte chemotaxis (GO:0002548) | 2.81334160 |
| 85 | germinal center formation (GO:0002467) | 2.80979082 |
| 86 | * JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.79928246 |
| 87 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.78486153 |
| 88 | granulocyte activation (GO:0036230) | 2.78383829 |
| 89 | detection of molecule of bacterial origin (GO:0032490) | 2.77402530 |
| 90 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.77365870 |
| 91 | regulation of growth of symbiont in host (GO:0044126) | 2.77365870 |
| 92 | negative regulation of growth of symbiont in host (GO:0044130) | 2.77365870 |
| 93 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.77365870 |
| 94 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.76706548 |
| 95 | myeloid dendritic cell activation (GO:0001773) | 2.76494062 |
| 96 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.74765748 |
| 97 | regulation of cholesterol storage (GO:0010885) | 2.74517222 |
| 98 | leukocyte cell-cell adhesion (GO:0007159) | 2.73492930 |
| 99 | modulation by symbiont of host cellular process (GO:0044068) | 2.72973689 |
| 100 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.72956169 |
| 101 | negative regulation of interleukin-6 production (GO:0032715) | 2.70505721 |
| 102 | regulation of interleukin-6 production (GO:0032675) | 2.69834130 |
| 103 | adhesion of symbiont to host cell (GO:0044650) | 2.69683228 |
| 104 | virion attachment to host cell (GO:0019062) | 2.69683228 |
| 105 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.69589880 |
| 106 | * interferon-gamma-mediated signaling pathway (GO:0060333) | 2.68273187 |
| 107 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.67135341 |
| 108 | positive regulation of transcription factor import into nucleus (GO:0042993) | 2.66601783 |
| 109 | detection of other organism (GO:0098543) | 2.65912223 |
| 110 | establishment of endothelial barrier (GO:0061028) | 2.65841532 |
| 111 | cellular response to biotic stimulus (GO:0071216) | 2.64399533 |
| 112 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.64169620 |
| 113 | negative regulation of cell killing (GO:0031342) | 2.64169620 |
| 114 | B cell mediated immunity (GO:0019724) | 2.63849096 |
| 115 | negative regulation of stress fiber assembly (GO:0051497) | 2.63840979 |
| 116 | Notch signaling involved in heart development (GO:0061314) | 2.62684391 |
| 117 | I-kappaB phosphorylation (GO:0007252) | 2.62579506 |
| 118 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.61836092 |
| 119 | adhesion of symbiont to host (GO:0044406) | 2.61554200 |
| 120 | mature B cell differentiation involved in immune response (GO:0002313) | 2.60554110 |
| 121 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.60339477 |
| 122 | cellular extravasation (GO:0045123) | 2.58915023 |
| 123 | negative regulation of amino acid transport (GO:0051956) | 2.58592052 |
| 124 | positive regulation of chemokine production (GO:0032722) | 2.58141798 |
| 125 | cytokine secretion (GO:0050663) | 2.56873263 |
| 126 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.53300787 |
| 127 | negative regulation of lipid storage (GO:0010888) | 2.52675524 |
| 128 | morphogenesis of an endothelium (GO:0003159) | 2.52545610 |
| 129 | endothelial tube morphogenesis (GO:0061154) | 2.52545610 |
| 130 | positive thymic T cell selection (GO:0045059) | 2.51354117 |
| 131 | positive regulation of heat generation (GO:0031652) | 2.50706668 |
| 132 | regulation of antigen processing and presentation (GO:0002577) | 2.50569678 |
| 133 | endothelial cell chemotaxis (GO:0035767) | 2.50130727 |
| 134 | myeloid dendritic cell differentiation (GO:0043011) | 2.46912666 |
| 135 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.46689270 |
| 136 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.46632309 |
| 137 | leukocyte tethering or rolling (GO:0050901) | 2.46589191 |
| 138 | regulation of toll-like receptor signaling pathway (GO:0034121) | 2.45851430 |
| 139 | regulation of interleukin-12 production (GO:0032655) | 2.44816405 |
| 140 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.44768140 |
| 141 | * regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.44457482 |
| 142 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.44439869 |
| 143 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.43382695 |
| 144 | wound healing, spreading of epidermal cells (GO:0035313) | 2.42748864 |
| 145 | response to interferon-alpha (GO:0035455) | 2.42727265 |
| 146 | regulation of p38MAPK cascade (GO:1900744) | 2.41824441 |
| 147 | positive regulation of interleukin-12 production (GO:0032735) | 2.40386932 |
| 148 | leukocyte aggregation (GO:0070486) | 2.40153540 |
| 149 | regulation of interferon-beta production (GO:0032648) | 2.39739790 |
| 150 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.39598784 |
| 151 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.39357260 |
| 152 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.38671752 |
| 153 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.37867698 |
| 154 | myeloid cell activation involved in immune response (GO:0002275) | 2.37333655 |
| 155 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.36984020 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 5.12010473 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.32550479 |
| 3 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.30878047 |
| 4 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 4.08237528 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.81444955 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.48461096 |
| 7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.00112213 |
| 8 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.91419677 |
| 9 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.83737489 |
| 10 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.77171701 |
| 11 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.66855753 |
| 12 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.65847374 |
| 13 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.46132931 |
| 14 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.41700346 |
| 15 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.33276743 |
| 16 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.14791785 |
| 17 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.12529075 |
| 18 | * KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 2.09229233 |
| 19 | * KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 2.09229233 |
| 20 | * KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 2.09229233 |
| 21 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.09218244 |
| 22 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.07506903 |
| 23 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.05418087 |
| 24 | * STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.00926810 |
| 25 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.93759888 |
| 26 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.90008322 |
| 27 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.89319575 |
| 28 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.88852177 |
| 29 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.87063355 |
| 30 | MYC_22102868_ChIP-Seq_BL_Human | 1.86798263 |
| 31 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.78491228 |
| 32 | MAF_26560356_Chip-Seq_TH1_Human | 1.77165418 |
| 33 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.76658095 |
| 34 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.76005806 |
| 35 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.74561188 |
| 36 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.71446870 |
| 37 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.68968751 |
| 38 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.62699368 |
| 39 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.60761011 |
| 40 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.60179327 |
| 41 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.59041506 |
| 42 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.54285235 |
| 43 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.53331130 |
| 44 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.51844999 |
| 45 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.51819440 |
| 46 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.50981523 |
| 47 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.49635685 |
| 48 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.49278290 |
| 49 | MYB_26560356_Chip-Seq_TH2_Human | 1.47288391 |
| 50 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.46378962 |
| 51 | GATA1_22025678_ChIP-Seq_K562_Human | 1.43926227 |
| 52 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.42945850 |
| 53 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.42814639 |
| 54 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.42599814 |
| 55 | * STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.41314363 |
| 56 | * MYB_26560356_Chip-Seq_TH1_Human | 1.39433292 |
| 57 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.39387741 |
| 58 | * NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.38980423 |
| 59 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.35622422 |
| 60 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.34928457 |
| 61 | UTX_26944678_Chip-Seq_JUKART_Human | 1.33436121 |
| 62 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.31979874 |
| 63 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.30157027 |
| 64 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.27641612 |
| 65 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.27367334 |
| 66 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.27337804 |
| 67 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.26901495 |
| 68 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.26438674 |
| 69 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.25756549 |
| 70 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.24763005 |
| 71 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.24671133 |
| 72 | SPI1_23127762_ChIP-Seq_K562_Human | 1.24541982 |
| 73 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.18606678 |
| 74 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.18606678 |
| 75 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.18297415 |
| 76 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.17714719 |
| 77 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16345437 |
| 78 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.13135087 |
| 79 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.10991049 |
| 80 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.10239414 |
| 81 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.10171655 |
| 82 | ATF3_27146783_Chip-Seq_COLON_Human | 1.09051194 |
| 83 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.08938933 |
| 84 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.08030260 |
| 85 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.07757422 |
| 86 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.07642806 |
| 87 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.07319779 |
| 88 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.07144173 |
| 89 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.06511339 |
| 90 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06435845 |
| 91 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.06273436 |
| 92 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06120177 |
| 93 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.06107204 |
| 94 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.04956207 |
| 95 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.04778099 |
| 96 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.04396875 |
| 97 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.02969916 |
| 98 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01918848 |
| 99 | * TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.01776031 |
| 100 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.01252266 |
| 101 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.00522226 |
| 102 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.00464296 |
| 103 | MAF_26560356_Chip-Seq_TH2_Human | 1.00165520 |
| 104 | * SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.99537993 |
| 105 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.99073980 |
| 106 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.97548680 |
| 107 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.95597277 |
| 108 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.95363805 |
| 109 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.94128587 |
| 110 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.93358309 |
| 111 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.93138587 |
| 112 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.92998534 |
| 113 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.91793103 |
| 114 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.91567006 |
| 115 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91531035 |
| 116 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.91047420 |
| 117 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.90039653 |
| 118 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89974617 |
| 119 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.89641839 |
| 120 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.89358576 |
| 121 | GATA1_19941826_ChIP-Seq_K562_Human | 0.89039494 |
| 122 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.84643420 |
| 123 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.84228847 |
| 124 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.83352837 |
| 125 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.82823165 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003436_decreased_susceptibility_to | 2.83105508 |
| 2 | * MP0003724_increased_susceptibility_to | 2.59253326 |
| 3 | MP0003300_gastrointestinal_ulcer | 2.48056683 |
| 4 | MP0004510_myositis | 2.41403695 |
| 5 | MP0002254_reproductive_system_inflammat | 2.37083550 |
| 6 | MP0009785_altered_susceptibility_to | 2.36315429 |
| 7 | MP0001835_abnormal_antigen_presentation | 2.33167123 |
| 8 | MP0004947_skin_inflammation | 2.27152171 |
| 9 | * MP0003303_peritoneal_inflammation | 2.24237039 |
| 10 | MP0005387_immune_system_phenotype | 2.22296129 |
| 11 | MP0001790_abnormal_immune_system | 2.22296129 |
| 12 | MP0000685_abnormal_immune_system | 2.19254335 |
| 13 | MP0006082_CNS_inflammation | 2.17668530 |
| 14 | * MP0005000_abnormal_immune_tolerance | 2.13921290 |
| 15 | MP0002419_abnormal_innate_immunity | 2.11488829 |
| 16 | MP0005076_abnormal_cell_differentiation | 2.08404986 |
| 17 | MP0005451_abnormal_body_composition | 2.00672251 |
| 18 | MP0002332_abnormal_exercise_endurance | 2.00454262 |
| 19 | MP0001851_eye_inflammation | 1.98834405 |
| 20 | MP0003705_abnormal_hypodermis_morpholog | 1.97385246 |
| 21 | MP0003828_pulmonary_edema | 1.97317108 |
| 22 | MP0005025_abnormal_response_to | 1.96420132 |
| 23 | MP0001800_abnormal_humoral_immune | 1.94554799 |
| 24 | * MP0009278_abnormal_bone_marrow | 1.94446382 |
| 25 | MP0010352_gastrointestinal_tract_polyps | 1.94339304 |
| 26 | MP0003448_altered_tumor_morphology | 1.94156495 |
| 27 | MP0003566_abnormal_cell_adhesion | 1.93675200 |
| 28 | MP0002148_abnormal_hypersensitivity_rea | 1.90738815 |
| 29 | MP0005023_abnormal_wound_healing | 1.89911416 |
| 30 | * MP0001533_abnormal_skeleton_physiology | 1.89500866 |
| 31 | MP0002452_abnormal_antigen_presenting | 1.89333754 |
| 32 | MP0009840_abnormal_foam_cell | 1.85911998 |
| 33 | * MP0002723_abnormal_immune_serum | 1.83134930 |
| 34 | MP0008438_abnormal_cutaneous_collagen | 1.80974587 |
| 35 | MP0003453_abnormal_keratinocyte_physiol | 1.78785408 |
| 36 | MP0000343_altered_response_to | 1.74672820 |
| 37 | MP0005257_abnormal_intraocular_pressure | 1.74085380 |
| 38 | MP0005671_abnormal_response_to | 1.67008062 |
| 39 | MP0010155_abnormal_intestine_physiology | 1.64319241 |
| 40 | * MP0002405_respiratory_system_inflammati | 1.60946437 |
| 41 | MP0005167_abnormal_blood-brain_barrier | 1.60153012 |
| 42 | MP0006054_spinal_hemorrhage | 1.60142944 |
| 43 | MP0001819_abnormal_immune_cell | 1.58225334 |
| 44 | MP0010307_abnormal_tumor_latency | 1.57425110 |
| 45 | MP0002420_abnormal_adaptive_immunity | 1.56816563 |
| 46 | MP0001853_heart_inflammation | 1.50912683 |
| 47 | MP0003075_altered_response_to | 1.46633025 |
| 48 | MP0002139_abnormal_hepatobiliary_system | 1.43781240 |
| 49 | * MP0001845_abnormal_inflammatory_respons | 1.41256580 |
| 50 | MP0005464_abnormal_platelet_physiology | 1.39899808 |
| 51 | MP0003690_abnormal_glial_cell | 1.39870750 |
| 52 | MP0010368_abnormal_lymphatic_system | 1.38512732 |
| 53 | MP0002166_altered_tumor_susceptibility | 1.36093248 |
| 54 | MP0002006_tumorigenesis | 1.34828370 |
| 55 | MP0003091_abnormal_cell_migration | 1.34528811 |
| 56 | MP0005275_abnormal_skin_tensile | 1.34173141 |
| 57 | MP0000858_altered_metastatic_potential | 1.33739320 |
| 58 | MP0003191_abnormal_cellular_cholesterol | 1.32490101 |
| 59 | MP0009333_abnormal_splenocyte_physiolog | 1.32376449 |
| 60 | MP0005058_abnormal_lysosome_morphology | 1.30416543 |
| 61 | MP0004272_abnormal_basement_membrane | 1.29949910 |
| 62 | MP0003763_abnormal_thymus_physiology | 1.28710845 |
| 63 | * MP0005397_hematopoietic_system_phenotyp | 1.27440922 |
| 64 | * MP0001545_abnormal_hematopoietic_system | 1.27440922 |
| 65 | MP0002998_abnormal_bone_remodeling | 1.25863492 |
| 66 | * MP0005390_skeleton_phenotype | 1.25760226 |
| 67 | MP0002933_joint_inflammation | 1.23649995 |
| 68 | MP0008469_abnormal_protein_level | 1.21138330 |
| 69 | MP0002398_abnormal_bone_marrow | 1.20181609 |
| 70 | * MP0000716_abnormal_immune_system | 1.17836314 |
| 71 | MP0000767_abnormal_smooth_muscle | 1.17808641 |
| 72 | MP0001501_abnormal_sleep_pattern | 1.14298410 |
| 73 | MP0003279_aneurysm | 1.13533390 |
| 74 | MP0009764_decreased_sensitivity_to | 1.08924196 |
| 75 | MP0005164_abnormal_response_to | 1.08923792 |
| 76 | MP0000465_gastrointestinal_hemorrhage | 1.08876482 |
| 77 | MP0001879_abnormal_lymphatic_vessel | 1.08565032 |
| 78 | MP0004858_abnormal_nervous_system | 1.07637886 |
| 79 | MP0001849_ear_inflammation | 1.04843145 |
| 80 | MP0003656_abnormal_erythrocyte_physiolo | 1.04054642 |
| 81 | * MP0000689_abnormal_spleen_morphology | 1.03548451 |
| 82 | * MP0002722_abnormal_immune_system | 1.02777145 |
| 83 | MP0005165_increased_susceptibility_to | 1.01816655 |
| 84 | MP0001958_emphysema | 1.01581200 |
| 85 | MP0002060_abnormal_skin_morphology | 1.01036042 |
| 86 | * MP0002429_abnormal_blood_cell | 0.98782741 |
| 87 | MP0003195_calcinosis | 0.97897718 |
| 88 | MP0000249_abnormal_blood_vessel | 0.97247372 |
| 89 | MP0002877_abnormal_melanocyte_morpholog | 0.96084267 |
| 90 | MP0000733_abnormal_muscle_development | 0.95639998 |
| 91 | MP0003045_fibrosis | 0.94052711 |
| 92 | MP0005166_decreased_susceptibility_to | 0.93073973 |
| 93 | MP0002277_abnormal_respiratory_mucosa | 0.92101933 |
| 94 | MP0001873_stomach_inflammation | 0.92038571 |
| 95 | * MP0004808_abnormal_hematopoietic_stem | 0.88858929 |
| 96 | MP0005310_abnormal_salivary_gland | 0.88780261 |
| 97 | MP0009765_abnormal_xenobiotic_induced | 0.88650054 |
| 98 | MP0005666_abnormal_adipose_tissue | 0.88603515 |
| 99 | MP0002396_abnormal_hematopoietic_system | 0.83215753 |
| 100 | MP0000703_abnormal_thymus_morphology | 0.82955091 |
| 101 | MP0004883_abnormal_blood_vessel | 0.82745862 |
| 102 | MP0005535_abnormal_body_temperature | 0.82613129 |
| 103 | MP0001915_intracranial_hemorrhage | 0.81466446 |
| 104 | MP0001216_abnormal_epidermal_layer | 0.81376529 |
| 105 | MP0000604_amyloidosis | 0.81134046 |
| 106 | MP0009763_increased_sensitivity_to | 0.81031872 |
| 107 | MP0002138_abnormal_hepatobiliary_system | 0.79701101 |
| 108 | MP0003172_abnormal_lysosome_physiology | 0.79135209 |
| 109 | MP0008004_abnormal_stomach_pH | 0.77676179 |
| 110 | MP0005595_abnormal_vascular_smooth | 0.76538735 |
| 111 | MP0001542_abnormal_bone_strength | 0.75760352 |
| 112 | MP0005647_abnormal_sex_gland | 0.75709811 |
| 113 | MP0005508_abnormal_skeleton_morphology | 0.74826287 |
| 114 | MP0000750_abnormal_muscle_regeneration | 0.74784201 |
| 115 | MP0008874_decreased_physiological_sensi | 0.72356459 |
| 116 | MP0003795_abnormal_bone_structure | 0.71531344 |
| 117 | MP0000920_abnormal_myelination | 0.67420155 |
| 118 | * MP0001663_abnormal_digestive_system | 0.63218478 |
| 119 | MP0003329_amyloid_beta_deposits | 0.62487875 |
| 120 | MP0003806_abnormal_nucleotide_metabolis | 0.60004292 |
| 121 | MP0005375_adipose_tissue_phenotype | 0.57601037 |
| 122 | MP0008260_abnormal_autophagy | 0.57570026 |
| 123 | MP0003646_muscle_fatigue | 0.57533485 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 4.70662631 |
| 2 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.20381946 |
| 3 | Orchitis (HP:0100796) | 3.98906676 |
| 4 | Systemic lupus erythematosus (HP:0002725) | 3.90883617 |
| 5 | Myositis (HP:0100614) | 3.90666846 |
| 6 | Loss of speech (HP:0002371) | 3.84670732 |
| 7 | Recurrent abscess formation (HP:0002722) | 3.75519726 |
| 8 | Hematochezia (HP:0002573) | 3.72675633 |
| 9 | Cerebral aneurysm (HP:0004944) | 3.46142000 |
| 10 | Disinhibition (HP:0000734) | 3.40149118 |
| 11 | Recurrent bacterial skin infections (HP:0005406) | 3.26785917 |
| 12 | Nuclear cataract (HP:0100018) | 3.24992817 |
| 13 | Optic neuritis (HP:0100653) | 3.22037358 |
| 14 | Retrobulbar optic neuritis (HP:0100654) | 3.22037358 |
| 15 | Stomatitis (HP:0010280) | 3.19853776 |
| 16 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.07112048 |
| 17 | Pustule (HP:0200039) | 3.04460871 |
| 18 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.01662713 |
| 19 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.01662713 |
| 20 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.01662713 |
| 21 | Mediastinal lymphadenopathy (HP:0100721) | 3.01006187 |
| 22 | Gangrene (HP:0100758) | 2.98628684 |
| 23 | Abnormality of the nasal mucosa (HP:0000433) | 2.94619105 |
| 24 | Myocardial infarction (HP:0001658) | 2.91451561 |
| 25 | Abnormality of macrophages (HP:0004311) | 2.91082067 |
| 26 | Neurofibrillary tangles (HP:0002185) | 2.89107530 |
| 27 | Interstitial pulmonary disease (HP:0006530) | 2.88488971 |
| 28 | Mucopolysacchariduria (HP:0008155) | 2.86396284 |
| 29 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.86396284 |
| 30 | Thick nail (HP:0001805) | 2.82495887 |
| 31 | Glomerulonephritis (HP:0000099) | 2.78728253 |
| 32 | Mutism (HP:0002300) | 2.78455952 |
| 33 | Increased IgM level (HP:0003496) | 2.77450619 |
| 34 | Osteolytic defects of the hand bones (HP:0009699) | 2.76957861 |
| 35 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.76957861 |
| 36 | Autoimmune thrombocytopenia (HP:0001973) | 2.73112084 |
| 37 | Spontaneous hematomas (HP:0007420) | 2.72119428 |
| 38 | Prostate neoplasm (HP:0100787) | 2.63929877 |
| 39 | Increased cerebral lipofuscin (HP:0011813) | 2.63236632 |
| 40 | Increased serum ferritin (HP:0003281) | 2.61207218 |
| 41 | Peritonitis (HP:0002586) | 2.60962577 |
| 42 | Chronic otitis media (HP:0000389) | 2.58814465 |
| 43 | Gingivitis (HP:0000230) | 2.51938614 |
| 44 | Premature rupture of membranes (HP:0001788) | 2.49292626 |
| 45 | Recurrent fungal infections (HP:0002841) | 2.48586020 |
| 46 | Esophageal varix (HP:0002040) | 2.46162534 |
| 47 | Polycythemia (HP:0001901) | 2.45463071 |
| 48 | Nasal polyposis (HP:0100582) | 2.44832451 |
| 49 | Abnormality of the pleura (HP:0002103) | 2.44238558 |
| 50 | Vasculitis (HP:0002633) | 2.42276379 |
| 51 | Hypergammaglobulinemia (HP:0010702) | 2.41273769 |
| 52 | Increased connective tissue (HP:0009025) | 2.40912536 |
| 53 | Arterial thrombosis (HP:0004420) | 2.39674244 |
| 54 | Parakeratosis (HP:0001036) | 2.34292762 |
| 55 | Autoimmune hemolytic anemia (HP:0001890) | 2.31569247 |
| 56 | Keratoconjunctivitis sicca (HP:0001097) | 2.29703148 |
| 57 | Polyneuropathy (HP:0001271) | 2.29648918 |
| 58 | Episodic fever (HP:0001954) | 2.28259251 |
| 59 | Pulmonary infiltrates (HP:0002113) | 2.26342287 |
| 60 | Cellulitis (HP:0100658) | 2.25600565 |
| 61 | Axonal loss (HP:0003447) | 2.24774730 |
| 62 | Joint swelling (HP:0001386) | 2.24256902 |
| 63 | Aortic aneurysm (HP:0004942) | 2.22694022 |
| 64 | Tetraparesis (HP:0002273) | 2.21448944 |
| 65 | Leukocytosis (HP:0001974) | 2.21401687 |
| 66 | Apathy (HP:0000741) | 2.21278899 |
| 67 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.20745467 |
| 68 | Milia (HP:0001056) | 2.19781573 |
| 69 | Emphysema (HP:0002097) | 2.19564263 |
| 70 | Encephalitis (HP:0002383) | 2.19266915 |
| 71 | Ankle contracture (HP:0006466) | 2.19186414 |
| 72 | Acne (HP:0001061) | 2.18575525 |
| 73 | Nephritis (HP:0000123) | 2.18332715 |
| 74 | Vertigo (HP:0002321) | 2.17720326 |
| 75 | Increased IgE level (HP:0003212) | 2.17475653 |
| 76 | Amyloidosis (HP:0011034) | 2.16836780 |
| 77 | Pulmonary embolism (HP:0002204) | 2.14768163 |
| 78 | Keratoconjunctivitis (HP:0001096) | 2.13729682 |
| 79 | Urethral obstruction (HP:0000796) | 2.12886325 |
| 80 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.12187757 |
| 81 | Porencephaly (HP:0002132) | 2.11054340 |
| 82 | Dilatation of the ascending aorta (HP:0005111) | 2.10991460 |
| 83 | T lymphocytopenia (HP:0005403) | 2.08959298 |
| 84 | Progressive neurologic deterioration (HP:0002344) | 2.08517396 |
| 85 | Meningitis (HP:0001287) | 2.08409767 |
| 86 | Diminished motivation (HP:0000745) | 2.08218902 |
| 87 | Asymmetric septal hypertrophy (HP:0001670) | 2.07813871 |
| 88 | Abnormality of glycolipid metabolism (HP:0010969) | 2.07427725 |
| 89 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.07427725 |
| 90 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.07427725 |
| 91 | Glomerulopathy (HP:0100820) | 2.07119477 |
| 92 | Abnormality of complement system (HP:0005339) | 2.05629601 |
| 93 | Purpura (HP:0000979) | 2.04864868 |
| 94 | Cerebral inclusion bodies (HP:0100314) | 2.04423613 |
| 95 | Malnutrition (HP:0004395) | 2.04095975 |
| 96 | Abnormality of iron homeostasis (HP:0011031) | 2.02893314 |
| 97 | Protrusio acetabuli (HP:0003179) | 2.00612373 |
| 98 | Aortic dissection (HP:0002647) | 2.00596962 |
| 99 | Thin bony cortex (HP:0002753) | 2.00273592 |
| 100 | Recurrent skin infections (HP:0001581) | 2.00013145 |
| 101 | Periodontitis (HP:0000704) | 2.00010044 |
| 102 | Shallow orbits (HP:0000586) | 1.99747734 |
| 103 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.99481107 |
| 104 | Recurrent viral infections (HP:0004429) | 1.98534648 |
| 105 | Keratitis (HP:0000491) | 1.97567466 |
| 106 | Complement deficiency (HP:0004431) | 1.97212321 |
| 107 | Alopecia of scalp (HP:0002293) | 1.96908142 |
| 108 | Abnormality of T cell number (HP:0011839) | 1.96659146 |
| 109 | Persistence of primary teeth (HP:0006335) | 1.96522953 |
| 110 | Arterial tortuosity (HP:0005116) | 1.96468508 |
| 111 | Neuronal loss in central nervous system (HP:0002529) | 1.96452098 |
| 112 | Arthralgia (HP:0002829) | 1.96242476 |
| 113 | Abnormality of the endocardium (HP:0004306) | 1.94459302 |
| 114 | Hemoptysis (HP:0002105) | 1.93876043 |
| 115 | Mitral valve prolapse (HP:0001634) | 1.92695573 |
| 116 | Vertebral compression fractures (HP:0002953) | 1.91426924 |
| 117 | Adactyly (HP:0009776) | 1.88026636 |
| 118 | Vascular tortuosity (HP:0004948) | 1.87977188 |
| 119 | Nausea (HP:0002018) | 1.87381159 |
| 120 | Premature loss of primary teeth (HP:0006323) | 1.86198064 |
| 121 | Hepatosplenomegaly (HP:0001433) | 1.86027290 |
| 122 | Thoracolumbar scoliosis (HP:0002944) | 1.84811332 |
| 123 | Atrophic scars (HP:0001075) | 1.84119747 |
| 124 | Ulnar bowing (HP:0003031) | 1.83629113 |
| 125 | Peripheral demyelination (HP:0011096) | 1.83251087 |
| 126 | Chronic obstructive pulmonary disease (HP:0006510) | 1.82795894 |
| 127 | Obstructive lung disease (HP:0006536) | 1.82795894 |
| 128 | Gastrointestinal infarctions (HP:0005244) | 1.82355723 |
| 129 | Urticaria (HP:0001025) | 1.80231719 |
| 130 | Inappropriate behavior (HP:0000719) | 1.79820079 |
| 131 | Skin ulcer (HP:0200042) | 1.79540594 |
| 132 | Colitis (HP:0002583) | 1.78682537 |
| 133 | Striae distensae (HP:0001065) | 1.78070584 |
| 134 | Pulmonary artery stenosis (HP:0004415) | 1.77946480 |
| 135 | Eosinophilia (HP:0001880) | 1.77342595 |
| 136 | Stomach cancer (HP:0012126) | 1.76385787 |
| 137 | Dysostosis multiplex (HP:0000943) | 1.75610041 |
| 138 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.75529557 |
| 139 | Vacuolated lymphocytes (HP:0001922) | 1.75511990 |
| 140 | Increased density of long bones (HP:0006392) | 1.75327516 |
| 141 | Conjunctival telangiectasia (HP:0000524) | 1.75264186 |
| 142 | Abnormality of the peritoneum (HP:0002585) | 1.74988781 |
| 143 | Short nail (HP:0001799) | 1.74450111 |
| 144 | Aneurysm (HP:0002617) | 1.73868998 |
| 145 | Abnormality of the pericardium (HP:0001697) | 1.69999072 |
| 146 | Basal ganglia calcification (HP:0002135) | 1.68408061 |
| 147 | Cervical subluxation (HP:0003308) | 1.67298493 |
| 148 | Anorexia (HP:0002039) | 1.65561152 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 3.23718169 |
| 2 | TGFBR2 | 3.19184074 |
| 3 | TYK2 | 3.02939916 |
| 4 | GRK7 | 2.93365468 |
| 5 | TAOK2 | 2.85438391 |
| 6 | MAPK15 | 2.83856962 |
| 7 | EPHB1 | 2.78479320 |
| 8 | MAP3K14 | 2.77873770 |
| 9 | TBK1 | 2.73325463 |
| 10 | PRPF4B | 2.49907181 |
| 11 | FGFR4 | 2.40382239 |
| 12 | MAP4K1 | 2.23198025 |
| 13 | EPHA3 | 2.18298724 |
| 14 | KDR | 2.18068452 |
| 15 | MAP3K3 | 2.17033093 |
| 16 | IRAK3 | 2.16847617 |
| 17 | JAK3 | 2.08307791 |
| 18 | JAK1 | 2.06064085 |
| 19 | TIE1 | 2.05167613 |
| 20 | IKBKE | 2.04527689 |
| 21 | STK10 | 2.01149852 |
| 22 | RIPK1 | 2.00954460 |
| 23 | IKBKB | 1.95390240 |
| 24 | BLK | 1.73316344 |
| 25 | BMPR2 | 1.70846854 |
| 26 | CDC42BPA | 1.68183984 |
| 27 | CSK | 1.67753778 |
| 28 | RPS6KA4 | 1.60424216 |
| 29 | TSSK6 | 1.60009469 |
| 30 | CHUK | 1.48557370 |
| 31 | TRIB3 | 1.43225127 |
| 32 | MAP3K10 | 1.42624926 |
| 33 | TXK | 1.42455450 |
| 34 | PTK6 | 1.40168715 |
| 35 | IRAK2 | 1.38062763 |
| 36 | FGFR3 | 1.37553785 |
| 37 | MAP2K3 | 1.34201122 |
| 38 | ZAP70 | 1.32401754 |
| 39 | CDK12 | 1.23597798 |
| 40 | EPHA2 | 1.22627421 |
| 41 | MARK3 | 1.15815676 |
| 42 | PIM1 | 1.15190390 |
| 43 | PIM2 | 1.09658629 |
| 44 | KIT | 1.09237507 |
| 45 | RIPK4 | 1.06469890 |
| 46 | MAP2K2 | 1.05084986 |
| 47 | PKN2 | 1.03350668 |
| 48 | HCK | 1.03307717 |
| 49 | PAK4 | 1.00670987 |
| 50 | IRAK4 | 0.99808807 |
| 51 | BMX | 0.94055385 |
| 52 | ITK | 0.93854667 |
| 53 | NLK | 0.93814879 |
| 54 | LATS2 | 0.93361731 |
| 55 | CSF1R | 0.93284063 |
| 56 | GSK3A | 0.92860151 |
| 57 | TTN | 0.91067455 |
| 58 | ADRBK2 | 0.89501673 |
| 59 | * JAK2 | 0.87277995 |
| 60 | MAP3K13 | 0.83820854 |
| 61 | TYRO3 | 0.80861298 |
| 62 | STK3 | 0.80793970 |
| 63 | TGFBR1 | 0.80036510 |
| 64 | MAPK7 | 0.78496040 |
| 65 | ABL2 | 0.77930973 |
| 66 | FGR | 0.76143082 |
| 67 | LRRK2 | 0.75098254 |
| 68 | SYK | 0.73831726 |
| 69 | ALK | 0.73596315 |
| 70 | MAP3K11 | 0.72371372 |
| 71 | CDK6 | 0.70855036 |
| 72 | PAK2 | 0.69546936 |
| 73 | SIK3 | 0.68620408 |
| 74 | PDGFRA | 0.67103283 |
| 75 | BTK | 0.66072626 |
| 76 | PDGFRB | 0.65577012 |
| 77 | * LCK | 0.65223337 |
| 78 | SIK1 | 0.64617615 |
| 79 | NME2 | 0.64519354 |
| 80 | TAOK1 | 0.63954606 |
| 81 | TAOK3 | 0.62571598 |
| 82 | MST4 | 0.62504113 |
| 83 | MAPKAPK2 | 0.62267195 |
| 84 | ICK | 0.60830923 |
| 85 | MATK | 0.59066725 |
| 86 | PTK2 | 0.57567439 |
| 87 | IRAK1 | 0.55958904 |
| 88 | MTOR | 0.54143068 |
| 89 | PRKG2 | 0.54115894 |
| 90 | FES | 0.52918381 |
| 91 | RPS6KC1 | 0.52533744 |
| 92 | RPS6KL1 | 0.52533744 |
| 93 | EGFR | 0.52430801 |
| 94 | MAP3K1 | 0.52042980 |
| 95 | GRK6 | 0.51854607 |
| 96 | MAP3K8 | 0.50532788 |
| 97 | PDK2 | 0.48990647 |
| 98 | ACVR1B | 0.48908847 |
| 99 | MOS | 0.47516584 |
| 100 | ERBB4 | 0.47452350 |
| 101 | MAP2K6 | 0.46606422 |
| 102 | MARK2 | 0.46313134 |
| 103 | RPS6KA5 | 0.46101519 |
| 104 | ABL1 | 0.45439277 |
| 105 | CDK4 | 0.45183859 |
| 106 | EEF2K | 0.44500075 |
| 107 | HIPK2 | 0.43685444 |
| 108 | TEC | 0.43426011 |
| 109 | PKN1 | 0.40797766 |
| 110 | MAP3K5 | 0.40574886 |
| 111 | LATS1 | 0.40118716 |
| 112 | RPS6KB2 | 0.39374043 |
| 113 | DMPK | 0.38227867 |
| 114 | MAPK4 | 0.37719941 |
| 115 | NEK2 | 0.36775506 |
| 116 | DYRK3 | 0.36582048 |
| 117 | LYN | 0.36257472 |
| 118 | CLK1 | 0.35274888 |
| 119 | DDR2 | 0.34481745 |
| 120 | PRKAA2 | 0.34117067 |
| 121 | PDK1 | 0.34111424 |
| 122 | PDPK1 | 0.34062824 |
| 123 | MAPKAPK3 | 0.32749516 |
| 124 | MAP3K6 | 0.32020410 |
| 125 | DYRK1B | 0.31991152 |
| 126 | RPS6KA6 | 0.31432712 |
| 127 | MELK | 0.31123983 |
| 128 | FER | 0.30287707 |
| 129 | RPS6KA2 | 0.28228362 |
| 130 | TNK2 | 0.27947566 |
| 131 | DAPK2 | 0.27713610 |
| 132 | MAPK3 | 0.24979106 |
| 133 | RPS6KA1 | 0.22156087 |
| 134 | FYN | 0.21221485 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 2.85135884 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.52907056 |
| 3 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.49278972 |
| 4 | Malaria_Homo sapiens_hsa05144 | 2.46900116 |
| 5 | * Osteoclast differentiation_Homo sapiens_hsa04380 | 2.45464305 |
| 6 | Legionellosis_Homo sapiens_hsa05134 | 2.12987031 |
| 7 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.12490385 |
| 8 | * TNF signaling pathway_Homo sapiens_hsa04668 | 2.10128684 |
| 9 | Toxoplasmosis_Homo sapiens_hsa05145 | 2.03818616 |
| 10 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.02130886 |
| 11 | Measles_Homo sapiens_hsa05162 | 2.00842956 |
| 12 | Pertussis_Homo sapiens_hsa05133 | 1.94838147 |
| 13 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.88036095 |
| 14 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.75211528 |
| 15 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.72352552 |
| 16 | * Influenza A_Homo sapiens_hsa05164 | 1.68535880 |
| 17 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.68279221 |
| 18 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.62661862 |
| 19 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.60544273 |
| 20 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.55387222 |
| 21 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.50451733 |
| 22 | Apoptosis_Homo sapiens_hsa04210 | 1.50353357 |
| 23 | Tuberculosis_Homo sapiens_hsa05152 | 1.47965588 |
| 24 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.45442486 |
| 25 | * Herpes simplex infection_Homo sapiens_hsa05168 | 1.44871657 |
| 26 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.42630551 |
| 27 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.38932442 |
| 28 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.38759069 |
| 29 | Amoebiasis_Homo sapiens_hsa05146 | 1.36792296 |
| 30 | * Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.36336069 |
| 31 | Hepatitis B_Homo sapiens_hsa05161 | 1.31855339 |
| 32 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.26981344 |
| 33 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.24954338 |
| 34 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.24562587 |
| 35 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.23729689 |
| 36 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.23537257 |
| 37 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.23256203 |
| 38 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.22049971 |
| 39 | Allograft rejection_Homo sapiens_hsa05330 | 1.19978992 |
| 40 | Shigellosis_Homo sapiens_hsa05131 | 1.19707961 |
| 41 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.19600358 |
| 42 | Prion diseases_Homo sapiens_hsa05020 | 1.19094684 |
| 43 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.18807520 |
| 44 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.18676360 |
| 45 | Salmonella infection_Homo sapiens_hsa05132 | 1.16830862 |
| 46 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.15937463 |
| 47 | Asthma_Homo sapiens_hsa05310 | 1.13355371 |
| 48 | Lysosome_Homo sapiens_hsa04142 | 1.12215029 |
| 49 | * Hepatitis C_Homo sapiens_hsa05160 | 1.08286067 |
| 50 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.04204482 |
| 51 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.03063508 |
| 52 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.99323351 |
| 53 | Focal adhesion_Homo sapiens_hsa04510 | 0.96903080 |
| 54 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.96359453 |
| 55 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.95245219 |
| 56 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.93850838 |
| 57 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.93084323 |
| 58 | HTLV-I infection_Homo sapiens_hsa05166 | 0.92726088 |
| 59 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.91913626 |
| 60 | Other glycan degradation_Homo sapiens_hsa00511 | 0.91286721 |
| 61 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.90165765 |
| 62 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.88595204 |
| 63 | Adherens junction_Homo sapiens_hsa04520 | 0.84993192 |
| 64 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.84656450 |
| 65 | Viral myocarditis_Homo sapiens_hsa05416 | 0.84371430 |
| 66 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.83613004 |
| 67 | * Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.83568772 |
| 68 | Phagosome_Homo sapiens_hsa04145 | 0.79195710 |
| 69 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.77674913 |
| 70 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.77112247 |
| 71 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.77106395 |
| 72 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.76370142 |
| 73 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.74156581 |
| 74 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.73691995 |
| 75 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.73011622 |
| 76 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.67840631 |
| 77 | Platelet activation_Homo sapiens_hsa04611 | 0.67191730 |
| 78 | Prostate cancer_Homo sapiens_hsa05215 | 0.66320647 |
| 79 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.65946927 |
| 80 | * Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.65896413 |
| 81 | Colorectal cancer_Homo sapiens_hsa05210 | 0.65003923 |
| 82 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.64268194 |
| 83 | * Insulin resistance_Homo sapiens_hsa04931 | 0.59664158 |
| 84 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.59386456 |
| 85 | Pathways in cancer_Homo sapiens_hsa05200 | 0.58647181 |
| 86 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.58370444 |
| 87 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.57533831 |
| 88 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.55477922 |
| 89 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.54608045 |
| 90 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.54350996 |
| 91 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.53872984 |
| 92 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.49931757 |
| 93 | Endocytosis_Homo sapiens_hsa04144 | 0.49712642 |
| 94 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.49607882 |
| 95 | Bladder cancer_Homo sapiens_hsa05219 | 0.49416413 |
| 96 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.47737698 |
| 97 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.47660158 |
| 98 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.46504676 |
| 99 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.46003966 |
| 100 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.45366253 |
| 101 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.42495428 |
| 102 | * Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.40635397 |
| 103 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.40562553 |
| 104 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.38676342 |
| 105 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.34727321 |
| 106 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.32848740 |
| 107 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.30462917 |
| 108 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.27273890 |
| 109 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.27176777 |
| 110 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.26924202 |
| 111 | Mineral absorption_Homo sapiens_hsa04978 | 0.25472393 |
| 112 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.23035696 |
| 113 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.22303847 |
| 114 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.18579972 |
| 115 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.18399310 |

